Samil Pharmaceutical Co.,Ltd (KRX:000520)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,290
+200 (1.80%)
At close: Feb 20, 2026
Market Cap239.68B -16.7%
Revenue (ttm)215.04B +1.2%
Net Income-27.06B
EPS-1,299.77
Shares Out21.23M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume604,670
Average Volume765,913
Open11,400
Previous Close11,090
Day's Range11,090 - 11,780
52-Week Range8,560 - 13,830
Beta0.37
RSI58.06
Earnings DateMar 13, 2026

About KRX:000520

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of pharmaceuticals in South Korea. It offers general medicines, including Tiersil Once, EYE2O mini eye drops, and Optagent ophthalmic drops; medical devices; secret spotpatch quasi-drugs, and roll away products. The company also provides specialty medicines, such as Hycell solutions; Curelen, Ocufridine, Ocumetholone, Ocucyclo, Ocuhomapine, Ocucarpine, Allerfen, Optanac, Forus, Eymox, Cifex, and Ocuracin ophthalmic drops; and Herpecid, Forus, and Ocurasin ophthalmic ointments. Sam... [Read more]

Sector Healthcare
Founded 1947
Employees 583
Stock Exchange Korea Stock Exchange
Ticker Symbol 000520
Full Company Profile

Financial Performance

Financial Statements